- Article
Expression Analysis of Circulating miR-21, miR-34a and miR-122 and Redox Status Markers in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients with and Without Type 2 Diabetes
- Sanja Erceg,
- Jelena Munjas,
- Miron Sopić,
- Ratko Tomašević,
- Miloš Mitrović,
- Jelena Kotur-Stevuljević,
- Milica Mamić,
- Sanja Vujčić,
- Aleksandra Klisic and
- Ana Ninić
Metabolic dysfunction-associated steatotic liver disease (MASLD), a hepatic form of metabolic syndrome, often co-occurs with type 2 diabetes (T2D) and now affects approximately 30% of the global population. MASLD encompasses conditions from simple st...